Dementia Treatment

Dementia: a regenerative approach to cognitive decline

Dementia is not a single disease, but a clinical syndrome involving the gradual deterioration of memory, language, reasoning, and executive function. It affects millions of people globally, including a rising number in India and Southeast Asia. The condition includes a wide range of subtypes such as Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia—each with distinct pathology but a shared outcome: progressive loss of brain function, independence, and quality of life.

At AMS Asia, we help patients and families explore regenerative options for dementia that go beyond managing symptoms. Through our network of leading clinical partners across Southeast Asia, we coordinate access to mesenchymal stem cell (MSC) therapy, exosome therapy, and integrative protocols supported by advanced diagnostics. These therapies aim to slow progression, restore function, and offer renewed hope for individuals living with cognitive decline.

Understanding the biology of dementia

While Alzheimer’s disease is the most recognized form of dementia, other types are increasingly diagnosed. What these conditions have in common is not just memory loss, but deeper systemic dysfunction across multiple biological systems. Dementia is not simply the result of aging or amyloid plaque buildup. Instead, it is a multifactorial disease involving:

• Microvascular damage and reduced brain perfusion

• Alpha-synuclein toxicity in Lewy body dementia

• Frontal and temporal lobe degeneration in FTD, leading to behavioral changes

• Mitochondrial dysfunction and oxidative stress

• Chronic neuroinflammation and glial dysregulation

• Insulin resistance and hormonal imbalances, sometimes described as “type 3 diabetes”

These biological disruptions impair neural connectivity, damage blood vessels in the brain, and ultimately accelerate cognitive decline.

Regenerative therapies: rebuilding the brain from within

AMS Asia connects patients with advanced therapies that work at the cellular level to address the core drivers of dementia. These therapies are most effective when started early and combined with a personalized treatment plan.
 

Mesenchymal Stem Cell (MSC) Therapy

MSCs are multipotent cells that regulate inflammation, promote tissue repair, and support neurovascular health. In dementia care, MSCs help by:

• Reducing neuroinflammation through downregulation of IL-6, TNF-α, and IL-1β

• Enhancing neurogenesis with the release of BDNF, NGF, and GDNF

• Improving cerebral perfusion by supporting blood vessel repair

• Stabilizing mitochondrial function and reducing oxidative stress

• Modulating microglial activity to protect synapses

Clinical observations have shown improvements in memory, attention, and mood stability following MSC therapy. Imaging studies have even reported reduced hippocampal atrophy with repeated treatments.
 

Exosome Therapy

Exosomes are nanoscale vesicles released by stem cells that carry proteins, microRNAs, and signaling molecules capable of promoting cellular repair. They offer a cell-free option for patients seeking safe, repeatable therapies.

Key benefits include:

• Delivery of anti-inflammatory and neuroprotective signals to brain tissue

• Restoration of microvascular health and glial function

• Modulation of gene expression to support neuron survival

• Minimal risk of immune reaction, allowing for frequent dosing

Exosome therapy is particularly well-suited for early and stable-stage dementia and can be used as a maintenance treatment over time. 

Precision diagnostics and comprehensive support

At AMS Asia, every dementia care journey begins with a detailed diagnostic evaluation. We coordinate testing with our partner labs and clinics to uncover the specific biological drivers of each case, ensuring that therapies are tailored and outcomes are measurable.
 

Core Diagnostics May Include:

• Inflammatory cytokine panels (IL-6, TNF-α, CRP)

• Mitochondrial and metabolic stress testing

• Hormonal profiling (thyroid, cortisol, insulin, testosterone)

• ApoE genetic risk assessment

• Cardiovascular and cerebral microvascular imaging

• Gut-brain axis analysis, including microbiome and toxin screening

• Cognitive function assessments (MoCA, MMSE, and neuropsychological testing)

This data-driven approach informs both the selection and monitoring of therapies and allows patients to track improvements over time.

Integrative support for cognitive stability

To complement regenerative treatments, AMS Asia helps patients access supportive therapies that enhance brain health, metabolic function, and neuroplasticity.

These may include:

• IV nutrient infusions with glutathione, NAD+, CoQ10, magnesium, and phosphatidylcholine

• Peptide therapy to promote neurogenesis and synaptic repair (e.g., BPC-157, dihexa, cerebrolysin)

• Bioidentical hormone optimization to improve endocrine support for cognitive resilience

• Lifestyle interventions, including sleep regulation, neurorehabilitation, and brain stimulation programs

• Targeted detoxification protocols for heavy metals and environmental toxins

This combination of regenerative and functional therapies creates a robust framework for long-term support and improved daily function.

Why patients, partners from India choose GAMA

AMS Asia is trusted by patients from India and beyond for our commitment to precision, transparency, and science-backed solutions. We are not a treatment center, but a consulting platform that connects patients to the most appropriate therapies and clinical providers across Southeast Asia.

Our partners operate in accredited facilities near major medical hubs, and we provide full coordination of diagnostics, treatment planning, and follow-up. We also collaborate with Indian hospitals, neurologists, and medical tourism facilitators, enabling seamless referrals and shared patient protocols.
 

Benefits of working with AMS Asia include:

• Access to cutting-edge regenerative therapies

• Internationally compliant protocols and ethical sourcing

• Data-driven personalization for each patient

• Coordination of all clinical and logistical needs

• Multilingual support and culturally informed care

• Transparent collaboration for healthcare providers in India

A New Direction in Dementia Treatment

Dementia does not have to mean a slow and inevitable decline. With the right approach, it is possible to target the biological causes of cognitive loss and support the brain’s ability to heal. AMS Asia brings together advanced biotechnology, functional medicine, and personalized care models to give patients a real opportunity for improvement.

If you or your loved one is facing early-stage dementia, or if you're a clinician seeking better tools for patient care, we are here to help.

Contact AMS Asia today to begin building a recovery pathway rooted in science, integrity, and the belief that cognitive renewal is possible.